NCT00511719View on ClinicalTrials.gov

Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

March 31, 2005

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Technosphere Insulin

48U

DRUG

Actrapid

24IU

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY